Denis Gravel

Director/Miembro de la Junta en Transdiff, Inc. .

Health Technology

Retail Trade

Distribution Services

Perfil

Denis Gravel is the founder of Enobia Pharma, Inc. which was founded in 1997.
Currently, he holds the position of Director at Transdiff, Inc. and Centre de Transmission J.D.H., Inc.

Cargos activos de Denis Gravel

Empresas	Cargo	Inicio
Transdiff, Inc. Transdiff, Inc. Specialty StoresRetail Trade Transdiff, Inc. provides truck dealership services. Its services include transmission, differential, engine, drive shaft, parts, mechanical service, and sale of new and used trucks. The company is headquartered in Quebec, Canada.	Director/Miembro de la Junta	-
Centre de Transmission J.D.H., Inc. Centre de Transmission J.D.H., Inc. Wholesale DistributorsDistribution Services Centre de Transmission J.D.H., Inc. engages in the sale of new trucks and Peterbilt parts and services. The company was founded in 1976 and is headquartered in Quebec, Canada.	Director/Miembro de la Junta	-

Todos los cargos activos de Denis Gravel

Antiguos cargos conocidos de Denis Gravel.

Empresas	Cargo	Fin
Enobia Pharma, Inc. Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada.	Fundador	-

Ver el detalle de la experiencia de Denis Gravel.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Denis Gravel.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Enobia Pharma, Inc. Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada.	Health Technology
Transdiff, Inc. Transdiff, Inc. Specialty StoresRetail Trade Transdiff, Inc. provides truck dealership services. Its services include transmission, differential, engine, drive shaft, parts, mechanical service, and sale of new and used trucks. The company is headquartered in Quebec, Canada.	Retail Trade
Centre de Transmission J.D.H., Inc. Centre de Transmission J.D.H., Inc. Wholesale DistributorsDistribution Services Centre de Transmission J.D.H., Inc. engages in the sale of new trucks and Peterbilt parts and services. The company was founded in 1976 and is headquartered in Quebec, Canada.	Distribution Services

Ver las conexiones de la empresa